Abstract
The persistence of covalently closed circular DNA (cccDNA) in the nucleus of liver cells is a key factor that hinders the cure of chronic hepatitis B. However, it is difficult to eliminate cccDNA with existing anti-HBV therapy. Recent studies have found that serum HBV RNA may be a new indicator reflecting the activity of cccDNA in hepatocytes and evaluating the clinical efficacy of CHB patients. This article reviews recent advances in the properties, detection methods, and clinical significance of HBV RNA, particularly the application of antiviral therapy in CHB patients. Key words: Hepatitis B, chronic; Hepatitis B virus; RNA, viral; DNA, circular; Nucleosides; Interferon-alpha; Polyethylene glycols
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
